BOB Capital Markets Ltd.
Expect Revenue per ANDA to grow by 5% CAGR from FY25-28E to Rs 114 mn in FY28 vs Rs 99 mn in FY25
Senores Pharmaceuticals has lost -18.18% in the last 1 Month
More from Senores Pharmaceuticals Ltd.
Recommended